TEDCO has announced a $200,000 investment into Rise Therapeutics, a Maryland-based biotechnology company. The funding will support Rise Therapeutics' ongoing clinical development efforts to bring their synthetic biology-based immunotherapy drugs to market.
TEDCO, Maryland's economic engine for technology companies, has invested $200,000 into Rise Therapeutics, a biotech company focused on developing innovative treatments for diseases. The funding will accelerate Rise Therapeutics' ongoing clinical development efforts and help bring their synthetic biology-based immunotherapy drugs to market. Rise Therapeutics has developed the Tripartite X drug delivery platform, which enables safe and effective oral delivery of biological therapies. TEDCO's Seed Funds provide investment opportunities to early-stage technology and life sciences companies in Maryland.